SCHEMBL568696

SCHEMBL568696

N#Cc1c(Cl)c2ccccc2n(Cc2ccc(F)cc2)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
HSD17B10 Q99714 1/20 0.52
PDE9A O76083 1/20 0.52
PDE1C Q14123 1/20 0.52
TSHR P16473 2/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HSPD1 P10809 1/20 0.48
HSPE1 P61604 1/20 0.48
LMNA P02545 1/20 0.48
CCR2 P41597 1/20 0.47
PLK1 P53350 1/20 0.45
TP53 P04637 3/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC11 Q96DB2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864205 0.89 PDE9A (0.63) ALDH1A1KDM4EPDE9APDE1CTSHR
SCHEMBL5528747 0.87 KDM4E (0.55) ALDH1A1KDM4EHSD17B10PDE9APDE1C
SCHEMBL568580 0.86 ALDH1A1 (0.51) ALDH1A1KDM4EHSD17B10PDE9APDE1C
SCHEMBL5531607 0.85 KDM4E (0.53) ALDH1A1KDM4EHSD17B10PDE9APDE1C
SCHEMBL5523464 0.85 PDE1C (0.50) ALDH1A1KDM4EHSD17B10PDE9APDE1C
SCHEMBL14375754 0.84 PDE9A (0.49) ALDH1A1KDM4EHSD17B10PDE9APDE1C
SCHEMBL2863880 0.84 P2RX4 (0.62) ALDH1A1KDM4EPDE9APDE1CSMN1; SMN2
SCHEMBL5525158 0.83 KDM4E (0.57) ALDH1A1KDM4EHSD17B10PDE9APDE1C
SCHEMBL23412054 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EPDE9APDE1CSMN1; SMN2
SCHEMBL29892161 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EPDE9APDE1CSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354640-A2 MIF INHIBITORS AND THEIR USES Innovimmune Biotherapeutics, Inc. (US) 2018-08-01 EP disclosed
EP-3354640-A2 MIF INHIBITORS AND THEIR USES Innovimmune Biotherapeutics, Inc. (US) 2018-08-01 EP disclosed
EP-2696682-B1 MIF INHIBITORS AND THEIR USES INNOVIMMUNE BIOTHERAPEUTICS INC (US) 2018-03-21 EP disclosed
EP-2696682-B1 MIF INHIBITORS AND THEIR USES INNOVIMMUNE BIOTHERAPEUTICS INC (US) 2018-03-21 EP disclosed
EP-2592933-B1 MIF INHIBITORS AND THEIR USES GAWECO ANDERSON (US) 2017-04-05 EP disclosed
EP-2592933-B1 MIF INHIBITORS AND THEIR USES GAWECO ANDERSON (US) 2017-04-05 EP disclosed
US-9133164-B2 MIF inhibitors and their uses INNOV88 LLC (US) 2015-09-15 US disclosed
US-9133164-B2 MIF inhibitors and their uses INNOV88 LLC (US) 2015-09-15 US disclosed
US-9133164-B2 MIF inhibitors and their uses INNOV88 LLC (US) 2015-09-15 US disclosed
US-9050334-B2 MIF inhibitors and their uses INNOV88 LLC (US) 2015-06-09 US disclosed
US-20070054923-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed
US-20070054923-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed
US-20070054923-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed
US-20070054920-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed
US-20070054920-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed
US-20070054920-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS 2007-03-08 US disclosed
US-7173036-B2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS (US) 2007-02-06 US disclosed
US-7173036-B2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS (US) 2007-02-06 US disclosed
US-7173036-B2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS (US) 2007-02-06 US disclosed
US-20040204586-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same AVANIR PHARMACEUTICALS, INC. 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054920-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same MIF, MSR1, MMP12 ALDH1A1 1799/4885KDM4E 2968/4885HSD17B10 3007/4885
US-20040204586-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same MIF, MSR1, MMP12 ALDH1A1 1446/4885KDM4E 3206/4885HSD17B10 2633/4885
US-20070054923-A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same MIF, MSR1, MMP12 ALDH1A1 1799/4885KDM4E 2968/4885HSD17B10 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.